Director CMC, Drug Substance
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
København N
Director CMC, Drug Substance
High degree of influence in a small but rapidly growing biotech company
https://uhc.dk/wp-content/uploads/2020/12/Director_CMC_Drug_Substance_Galecto.mp4
Galecto Biotech is a biotech company with offices in Copenhagen, London, Montreal, Gothenburg, Edinburgh and Boston. Galecto Biotech develops galectin modulators for the treatment of severe diseases, focusing on fibrosis and cancer. The most advanced program is in clinical Phase IIb for the treatment of Idiopathic Pulmonary Fibrosis.
As the CMC area within Galecto expands, they are looking for a highly motivated and skilled chemist to support CMC activities focused on API development and manufacture. This role offers the unique opportunity to be part of, and obtain experience in, the drug development process from preclinical through to the clinical phases in a dynamic and growing company.
You will report to the Chief Operating Officer in Galecto and work closely with colleagues within CMC, Medicinal Chemistry, Nonclinical and Formulation development.
The main responsibilities are:
Ideally, you hold a relevant university degree – preferably a Master of Science in Chemistry, Engineering, Pharmacy, or the like. A PhD is preferred but not a requirement.
The successful applicant will already have a proven record of accomplishment in delivering APIs manufactured according to GMP to deadline and on budget. The following qualifications are preferred:
You are proficient in English on a professional level, both written and spoken.
You are an independent and self-motivated person with a proactive attitude towards your tasks and stakeholders. You are a team player and thrive in a flat structure with short lines of command. Your enthusiasm and creative problem solving leads to unique solutions and results. You are inquisitive, curious and able to acquire new skills as projects demand and you are willing to contribute wherever needed.
Galecto Biotech offers you an exciting and challenging position in an entrepreneurial, science driven and international company with a short line of command. You will be involved in activities that are central to Galecto’s strategy and work together with highly skilled and experienced colleagues to advance the exciting product pipeline.
Travelling: 5 -15 days/year.
Place of work: Galecto Biotech is a global company and place of work can be in one of the Galecto offices in Copenhagen, London, Montreal or Gothenburg.
For more details about the job or the company, please contact CEO Jørn Duhn, Unique Human Capital on M: +45 21 75 19 25 or Senior Research Consultant Elisabeth Haun, Unique Human Capital on M: +45 28 90 33 88. All applications must be in English and are treated confidentially.
High degree of influence in a small but rapidly growing biotech company
https://uhc.dk/wp-content/uploads/2020/12/Director_CMC_Drug_Substance_Galecto.mp4
Galecto Biotech is a biotech company with offices in Copenhagen, London, Montreal, Gothenburg, Edinburgh and Boston. Galecto Biotech develops galectin modulators for the treatment of severe diseases, focusing on fibrosis and cancer. The most advanced program is in clinical Phase IIb for the treatment of Idiopathic Pulmonary Fibrosis.
As the CMC area within Galecto expands, they are looking for a highly motivated and skilled chemist to support CMC activities focused on API development and manufacture. This role offers the unique opportunity to be part of, and obtain experience in, the drug development process from preclinical through to the clinical phases in a dynamic and growing company.
You will report to the Chief Operating Officer in Galecto and work closely with colleagues within CMC, Medicinal Chemistry, Nonclinical and Formulation development.
The main responsibilities are:
- Management of Galecto Biotech’s outsourced API activities including initial route identification and process development for new drug candidates through process scale up for the various stages of development
- CMO selection at each stage of development including generation of RFP and review of submitted bids/proposals
- Ensuring, with legal input, that appropriate contracts including MSA’s and QTA’s are in place and appropriate for the phase of manufacture
- Providing scientific input and guidance to the CMO throughout the process development and manufacturing including supporting analytical development activities
- Reviewing and approving the documentation generated by the CMO such as master batch records, specifications, validation and stability protocols and reports and campaign/development reports
- Coordinating API manufacturing activities with internal project teams to ensure sufficient API available for nonclinical toxicology and efficacy studies as well as drug product development and manufacturing needs at the various stages of development
- Communicating key information on project progress and risks to project teams and line management in a timely manner
- Preparing CMC documentation for regulatory submission (IND Module 3, IMPD) and responding to API related regulatory questions
- Ensuring compliance with current regulatory requirements via PGI and nitrosamine assessments and phase appropriate understanding of sources and purging of process impurities
Ideally, you hold a relevant university degree – preferably a Master of Science in Chemistry, Engineering, Pharmacy, or the like. A PhD is preferred but not a requirement.
The successful applicant will already have a proven record of accomplishment in delivering APIs manufactured according to GMP to deadline and on budget. The following qualifications are preferred:
- Minimum 10 years of experience with process development for the manufacture of pharmaceuticals in fixed assets
- A strong understanding of organic chemistry
- An understanding of the regulatory requirements for manufacture of API for different clinical phases
- Experience with project management of CMC activities covering process development, analytical development, and plant manufacture
- Experience with outsourcing projects to external CDMOs
- Experience with training and growing a team
You are proficient in English on a professional level, both written and spoken.
You are an independent and self-motivated person with a proactive attitude towards your tasks and stakeholders. You are a team player and thrive in a flat structure with short lines of command. Your enthusiasm and creative problem solving leads to unique solutions and results. You are inquisitive, curious and able to acquire new skills as projects demand and you are willing to contribute wherever needed.
Galecto Biotech offers you an exciting and challenging position in an entrepreneurial, science driven and international company with a short line of command. You will be involved in activities that are central to Galecto’s strategy and work together with highly skilled and experienced colleagues to advance the exciting product pipeline.
Travelling: 5 -15 days/year.
Place of work: Galecto Biotech is a global company and place of work can be in one of the Galecto offices in Copenhagen, London, Montreal or Gothenburg.
For more details about the job or the company, please contact CEO Jørn Duhn, Unique Human Capital on M: +45 21 75 19 25 or Senior Research Consultant Elisabeth Haun, Unique Human Capital on M: +45 28 90 33 88. All applications must be in English and are treated confidentially.
Information og data
Denne ledige stilling har jobtypen "Afdelingsleder", og befinder sig i kategorien "Ledelse og personale".
Arbejdsstedet er beliggende i København N.
Jobbet er oprettet på vores service den 4.12.2020, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Afdelingsleder
- København N
Lignende jobs
-
Senior Product Manager - Product Discovery
Opportunity Working at Maersk brings a unique blend of being part of a rich heritage and an enthusiastic, innovative, fast-paced logistics company. We believe in rewarding and recognizing individ..- Afdelingsleder
- København K
-
Seniorprojektleder til Spildevand Plan [xxxxx]
Bindeled mellem projektchefer og projektledere på regn -og spildevandsprojekter Som vores kommende kollega skal du være med til at omsætte projektstrategier til konkrete projekter. I den forbind..- Afdelingsleder
- København S
-
Teamleder til kryds- og omlægninger i [xxxxx]
[xxxxx] hjælper omverdenen med at beskytte vores forsyninger, når byerne forandres og fortættes. [xxxxx] har et stort net af forsyningsinfrastruktur i hovedstadsområdet, som er afgørende for at vi .- Afdelingsleder
- København S
-
Advisor for Global Partnerships and Resource Mobil...
DanChurchAid (DCA) is looking for an energetic and committed person with documented experience in forming and supporting global partnerships, consortia, and resource mobilization for international .- Afdelingsleder
- København
Statistik over udbudte jobs som afdelingsleder i København N
Herunder ser du udviklingen i udbudte afdelingsleder i København N over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal afdelingsleder.
Se flere statistikker her:
Statistik over udbudte afdelingsleder i København N over tid
Dato | Alle jobs som afdelingsleder |
---|---|
28. december 2024 | 4 |
27. december 2024 | 4 |
26. december 2024 | 4 |
25. december 2024 | 4 |
24. december 2024 | 3 |
23. december 2024 | 4 |
22. december 2024 | 3 |
21. december 2024 | 4 |
20. december 2024 | 4 |
19. december 2024 | 4 |
18. december 2024 | 4 |
17. december 2024 | 3 |
16. december 2024 | 3 |
15. december 2024 | 3 |
14. december 2024 | 3 |
13. december 2024 | 3 |
12. december 2024 | 3 |
11. december 2024 | 4 |
10. december 2024 | 4 |
9. december 2024 | 4 |
8. december 2024 | 4 |
7. december 2024 | 3 |
6. december 2024 | 3 |
5. december 2024 | 3 |
4. december 2024 | 4 |
3. december 2024 | 2 |
2. december 2024 | 2 |
1. december 2024 | 2 |
30. november 2024 | 2 |
29. november 2024 | 2 |
28. november 2024 | 2 |